The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC

Annals of Clinical and Translational Neurology recently published this article where the authors identified that the kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC. This opens door for potential therapeutic intervention trials.

The kynurenine pathway relates to post‐acute COVID‐19 objective cognitive impairment and PASC (wiley.com)